Table 2 Maternal and neonatal demographics and clinical characteristics of infants newly diagnosed with cerebral palsy from 2021 to 2023.
2021 (n = 5) | 2022 (n = 10) | 2023 (n = 11) | p-valuea | |
---|---|---|---|---|
Gestational Age (weeks) | 26.8 (1.97) | 27.1 (3.39) | 35.5 (6.59) | 0.0009 |
Birthweight (Z-score)b | 0.468 (2.26) | −0.539 (0.988) | −0.130 (1.13) | 0.41 |
Male Sex | 3 (60) | 6 (60) | 6 (54.5) | 1.00 |
Race | 0.43 | |||
Asian | 1 (20) | 0 (0) | 0 (0) | |
Black | 2 (40) | 3 (30) | 5 (45.5) | |
White | 2 (40) | 7 (70) | 6 (54.5) | |
Hispanic ethnicity | 1 (20) | 7 (70) | 4 (36.4) | 0.15 |
Antenatal steroids | 5 (100) | 10 (100) | 3 (27.3) | 0.0003 |
Maternal magnesium | 5 (100) | 10 (100) | 3 (27.3) | 0.0003 |
Small for gestational age | 0 (0) | 2 (20) | 2 (18.2) | 0.82 |
Multiple gestation | 0 (0) | 2 (20) | 3 (27.3) | 0.69 |
Therapeutic hypothermia | 0 (0) | 0 (0) | 4 (36.4) | 0.05 |
Abnormal neuroimagingc | 4 (80) | 7 (70) | 10 (91) | 0.57 |
GMA writhing period | - | - | - | |
Normal | 0 (0) | |||
Poor repertoire | 3 (100) | |||
Cramped synchronized | 0 (0) | |||
GMA fidgety period | - | - | - | |
Normal | 2 (33) | |||
Absent | 4 (67 | |||
CP tone type | 0.22 | |||
Spasticity | 4 (80) | 10 (100) | 8 (73) | |
Hypotonia | 1 (20) | 0 (0) | 3 (27) | |
CP topography | 0.34 | |||
Hemiplegia | 2 (40) | 1 (10) | 4 (36) | |
Diplegia | 2 (40) | 5 (50) | 3 (27) | |
Triplegia | 0 (0) | 1 (10) | 0 (0) | |
Quadriplegia | 1 (20) | 3 (30) | 4 (36) | |
Gross motor function classification level | 0.11 d | |||
I | 3 (60) | 1 (10) | - | |
II | 0 (0) | 3 (30) | - | |
III | 1 (20) | 0 (0) | - | |
IV-V | 1 (20) | 4 (40) | - | |
Unclassified | 0 (0) | 2 (20) | 11 (100) | |
Age at diagnosis (months) | 18.5 [16.7, 19.4] | 7.5 [5.9, 14.4] | 8.9 [6.6, 12.2] | 0.02e, 0.01 f, 0.48 g |